glucosamine/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Increases prostate cancer incidence
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.Finding“During a median of 12.5 years follow-up, glucosamine use was significantly associated with an increased risk of overall cancer [HR, 1.04; 95% confidence interval (CI), 1.01-1.06], skin cancer (HR, 1.11; 95% CI, 1.07-1.15), and prostate cancer (HR, 1.07; 95% CI, 1.01-1.13), and with a reduced risk of lung cancer (HR, 0.88; 95% CI, 0.79-0.97) after adjusting for potential confounders.”
Quoted verbatim from Regular Glucosamine Use May Have Different Roles in the Risk of Site-Specific Cancers: Findings from a Large Prospective Cohort.. - Study
- cohort
- Population
- UK Biobank adults free of cancer at baseline, regular glucosamine users versus non-users
Effect 1.07 hazard ratio, 95% CI 1.01 to 1.13
Regular Glucosamine Use May Have Different Roles in the Risk of Site-Specific Cancers: Findings from a Large Prospective Cohort.2023PMID:36716122Permalink
Keep reading
- Everything the graph holds on glucosamine
- Every compound studied against Prostate cancer incidence
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4Q3J0PP092HCD1K03JP5P4K